Two obstacles in #CancerImmunotherapy are tumor-infiltrating T cell exhaustion & mitochondrial dysfunction. Drs. @yapeng-su.bsky.social & Philip Greenberg at @fredhutch.org & @uwdeptmedicine.bsky.social identified KLHL6 as a dual-negative regulator of both. Abstract: go.nature.com/4qqLAsK